181 related articles for article (PubMed ID: 37487316)
1. A thorough understanding of the role of lncRNA in prostate cancer pathogenesis; Current knowledge and future research directions.
Haghighi R; Castillo-Acobo RY; H Amin A; Ehymayed HM; Alhili F; Mirzaei M; Mohammadzadeh Saliani S; Kheradjoo H
Pathol Res Pract; 2023 Aug; 248():154666. PubMed ID: 37487316
[TBL] [Abstract][Full Text] [Related]
2. Updated review on analysis of long non-coding RNAs as emerging diagnostic and therapeutic targets in prostate cancers.
Ke Z; Hu X; Liu Y; Shen D; Khan MI; Xiao J
Crit Rev Oncol Hematol; 2024 Apr; 196():104275. PubMed ID: 38302050
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
[TBL] [Abstract][Full Text] [Related]
4. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
[TBL] [Abstract][Full Text] [Related]
5. The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management.
Ramnarine VR; Kobelev M; Gibb EA; Nouri M; Lin D; Wang Y; Buttyan R; Davicioni E; Zoubeidi A; Collins CC
Eur Urol; 2019 Nov; 76(5):546-559. PubMed ID: 31445843
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a novel long noncoding RNA overlapping the LCK gene that regulates prostate cancer cell growth.
Ta HQ; Whitworth H; Yin Y; Conaway M; Frierson HF; Campbell MJ; Raj GV; Gioeli D
Mol Cancer; 2019 Jun; 18(1):113. PubMed ID: 31253147
[TBL] [Abstract][Full Text] [Related]
7. SP1-mediated upregulation of lncRNA SNHG4 functions as a ceRNA for miR-377 to facilitate prostate cancer progression through regulation of ZIC5.
Wang ZY; Duan Y; Wang P
J Cell Physiol; 2020 Apr; 235(4):3916-3927. PubMed ID: 31608997
[TBL] [Abstract][Full Text] [Related]
8. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
Ye Y; Li SL; Wang SY
PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
[TBL] [Abstract][Full Text] [Related]
9. Role of lncRNAs in prostate cancer development and progression.
Weiss M; Plass C; Gerhauser C
Biol Chem; 2014 Nov; 395(11):1275-90. PubMed ID: 25153594
[TBL] [Abstract][Full Text] [Related]
10. Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer.
Chen Y; Chen Z; Mo J; Pang M; Chen Z; Feng F; Xie P; Yang B
Technol Cancer Res Treat; 2021; 20():1533033821990064. PubMed ID: 33596783
[TBL] [Abstract][Full Text] [Related]
11. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.
Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y
Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971
[TBL] [Abstract][Full Text] [Related]
12. The functional significance and cross-talk of non-coding RNAs in triple negative and quadruple negative breast cancer.
Paul U; Banerjee S
Mol Biol Rep; 2022 Jul; 49(7):6899-6918. PubMed ID: 35235157
[TBL] [Abstract][Full Text] [Related]
13. [Roles of long non-coding RNAs in prostate cancer and their action mechanisms].
Li ZF; Xiao N; Yao YW; Yao ZF
Zhonghua Nan Ke Xue; 2022 Dec; 28(12):1129-1135. PubMed ID: 37846635
[TBL] [Abstract][Full Text] [Related]
14. Long Non-coding RNA AFAP1-AS1 Facilitates Prostate Cancer Progression by Regulating miR-15b/IGF1R Axis.
Liu B; Jiang HY; Yuan T; Zhou WD; Xiang ZD; Jiang QQ; Wu DL
Curr Pharm Des; 2021; 27(41):4261-4269. PubMed ID: 34126893
[TBL] [Abstract][Full Text] [Related]
15. A novel androgen-reduced prostate-specific lncRNA, PSLNR, inhibits prostate-cancer progression in part by regulating the p53-dependent pathway.
Wang D; Wan X; Zhang Y; Kong Z; Lu Y; Sun X; Huang Y; Ji C; Li D; Luo J; Gu W; Wang C; Li Y; Xu Y
Prostate; 2019 Sep; 79(12):1362-1377. PubMed ID: 31269242
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer.
Huang W; Su X; Yan W; Kong Z; Wang D; Huang Y; Zhai Q; Zhang X; Wu H; Li Y; Li T; Wan X
Prostate; 2018 Dec; 78(16):1248-1261. PubMed ID: 30105831
[TBL] [Abstract][Full Text] [Related]
17. AAT resistance-related AC007405.2 and AL354989.1 as novel diagnostic and prognostic markers in prostate cancer.
Deng Y; Zhang C; Yu H; Chen G; Peng X; Li Y; Feng Z; Shi W; Bai X; Gou X; Liu N
Aging (Albany NY); 2024 Apr; 16(8):7249-7266. PubMed ID: 38643469
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of LncRNA SNHG7 inhibited epithelial-mesenchymal transition in prostate cancer though miR-324-3p/WNT2B axis in vitro.
Han Y; Hu H; Zhou J
Pathol Res Pract; 2019 Oct; 215(10):152537. PubMed ID: 31324390
[TBL] [Abstract][Full Text] [Related]
19. Expression status and prognostic value of autophagy-related lncRNAs in prostate cancer.
Chen G; Qin X; Wang Y; Gao B; Ling M; Yin W; Li Y; Pan B
Cell Cycle; 2022 Aug; 21(16):1684-1696. PubMed ID: 35414328
[TBL] [Abstract][Full Text] [Related]
20. Long non-‑coding RNA SNHG16 functions as a tumor activator by sponging miR‑373‑3p to regulate the TGF‑β‑R2/SMAD pathway in prostate cancer.
Weng W; Liu C; Li G; Ruan Q; Li H; Lin N; Chen G
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34643247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
